1. H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts.
- Author
-
Yagita A, Maruyama S, Wakasugi S, and Sukegawa Y
- Subjects
- Adenocarcinoma, Adjuvants, Immunologic chemistry, Adjuvants, Immunologic therapeutic use, Animals, Antineoplastic Agents chemistry, Carcinoma, Lewis Lung, Colonic Neoplasms, Haplotypes, Mice, Mice, Congenic, Mice, Inbred BALB C, Mice, Inbred C57BL, Mycelium chemistry, Plant Extracts chemistry, Proteoglycans chemistry, Proteoglycans therapeutic use, Antineoplastic Agents therapeutic use, Basidiomycota chemistry, H-2 Antigens immunology, Interleukin-12 blood, Neoplasms, Experimental blood, Neoplasms, Experimental drug therapy, Neoplasms, Experimental immunology, Plant Extracts therapeutic use
- Abstract
IL-12 is considered to be one of the most important cytokines in anti-cancer therapy. We have demonstrated that substances derived from Basidiomycetes, such as active hexose-correlated compound (AHCC) and PSK induce the production of IL-12. In this study, the MHC dependency of IL-12 production induced by various mycelial extracts, PSK, AHCC and IL-X, was examined. During tumor-bearing, higher serum IL-12 levels were observed in H-2a and H-2b mice as compared to H-2d mice. Concerning the effect of genetic background of mice on response to mycelial extracts, AHCC administration enhanced the serum IL-12 level in H-2b mice but not in H-2d mice, while PSK administration increased the serum IL-12 level in H-2d mice but not in H-2b mice. IL-X, components derived from the same Basidiomycetes, also enhanced the serum IL-12 level in H-2b mice in the early stage of tumor like AHCC, and maintained serum IL-12 at a level higher than the normal value accompanying tumor growth, whereas AHCC did not restore the lowered serum IL-12 level accompanying tumor growth. These results showed that AHCC or IL-X is effective in a genetically Th1-dominant individual whereas PSK is effective in a genetically Th2-dominant individual or Th2-dominant status in advanced cancer patients. So we propose that the suitable combinations of various mycelial extracts may be effective methods of endogenous IL-12 induction for cancer patients of all stages, which is important as a cancer therapy that is relatively free from adverse reactions and which emphasizes the QOL in individual patients.
- Published
- 2002